6,439
Views
32
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections

ORCID Icon, &
Pages 479-488 | Received 01 Oct 2019, Accepted 08 Apr 2020, Published online: 22 Apr 2020

References

  • Troeger C, Forouzanfar M, Rao PC, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(11):1133–1161.
  • Nauclér P. Rapport Från Pneumoniregistret 2017. 2018. [cited 2020 Apr 13]. Available from: http://infektion.net/wp-content/uploads/2018/11/kvalreg_inf_2017_pneumoni.pdf.
  • Vos LM, Bruning AHL, Reitsma JB, et al. Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review of diagnostic accuracy and clinical impact studies. Clin Infect Dis. 2019;69(7):1243–1253.
  • Pulido MR, Moreno-Martínez P, González-Galán V, et al. Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia. Clin Microbiol Infect. 2018;24(11):1213.e1–1213.e4.
  • Baudel J-L, Tankovic J, Dahoumane R, et al. Multiplex PCR performed of bronchoalveolar lavage fluid increases pathogen identification rate in critically ill patients with pneumonia: a pilot study. Ann Intensive Care. 2014;4(1):35.
  • Ullberg M, Lüthje P, Mölling P, et al. Broad-range detection of microorganisms directly from bronchoalveolar lavage specimens by PCR/electrospray ionization-mass spectrometry. PLoS One. 2017;12(1):e0170033.
  • Gadsby NJ, McHugh MP, Forbes C, et al. Comparison of Unyvero P55 Pneumonia Cartridge, in-house PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care setting. Eur J Clin Microbiol Infect Dis. 2019;38(6):1171–1178.
  • Gadsby NJ, McHugh MP, Russell CD, et al. Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections. Clin Microbiol Infect. 2015;21(8):e788.e1–788.e13.
  • Edin A, Granholm S, Koskiniemi S, et al. Development and laboratory evaluation of a quantitative real-time PCR assay for detecting viruses and bacteria of relevance for community-acquired pneumonia. J Mol Diagnostics. 2015:17(3):315–324.
  • Simusika P, Bateman AC, Theo A, et al. Identification of viral and bacterial pathogens from hospitalized children with severe acute respiratory illness in Lusaka, Zambia, 2011-2012. BMC Infect Dis. 2015;15(1):2011–2012.
  • Haessler S, Lagu T, Lindenauer PK, et al. Treatment trends and outcomes in healthcare-associated pneumonia. J Hosp Med. 2017;12(11):886–891.
  • Webb BJ, Sorensen J, Jephson A, et al. Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J. 2019;54(1):1900057.
  • Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241.
  • Gadsby NJ, Russell CD, Mchugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817–823.
  • Hallander H, Thore M, Olsson-Liljequist B, et al. Referensmetodik I 2: Nedre Luftvägsinfektioner. 2nd ed. Swedish Institute for Infectious disease Control. Stockholm: SBL; 2005. Available from: http://referensmetodik.folkhalsomyndigheten.se/w/Referensmetodik:_Nedre_luftvägsinfektioner,_2:a_upplagan_2005.
  • Richter C, Hollstein S, Woloszyn J, et al. Evaluation of species-specific score cut-off values for various Staphylococcus species using a MALDI Biotyper-based identification. J Med Microbiol. 2012;61(Pt 10):1409–1416.
  • Matuschek E, Brown DFJ, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20(4):O255–O266.
  • Giske C. Nordic Committee on Antimicrobial Susceptibility Testing, Enterobacteriaceae: Detection of ESBL A/ESBLM/ESBLCARBA. [cited 2020 Apr 2]. Available from: http://nordicast.intranet2.se/d/2612?store_referer=true.
  • Francois P, Pittet D, Bento M, et al. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol. 2003;41(1):254–260.
  • Public Health Agency of Sweden. 2018. [cited 2020 Apr 13]. Available from: www.folkhalsomyndigheten.se.
  • Hernroth BE, Conden-Hansson A-C, Rehnstam-Holm A-S, et al. Environmental Factors influencing human viral pathogens and their potential indicator organisms in the Blue Mussel, Mytilus edulis: the first Scandinavian report. Appl Environ Microbiol. 2002;68(9):4523–4533.
  • Brittain-Long R, Nord S, Olofsson S, et al. Multiplex real-time PCR for detection of respiratory tract infections. J Clin Virol. 2008;41(1):53–56.
  • Tiveljung-Lindell A, Rotzén-Östlund M, Gupta S, et al. Development and implementation of a molecular diagnostic platform for daily rapid detection of 15 respiratory viruses. J Med Virol. 2009;81(1):167–175.
  • Gullsby K, Storm M, Bondeson K. Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR. J Clin Microbiol. 2008;46(2):727–731.
  • Lee J, Lee J. Performance evaluation of Allplex Respiratory Panels 1, 2, and 3 for the detection of respiratory viral infection. Clin Lab. 2019;65(1). DOI:10.7754/Clin.Lab.2018.180730
  • Babady NE. The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn. 2013;13(8):779–788.
  • Athlin S, Lidman C, Lundqvist A, et al. Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infect Dis (Auckl). 2018;50(4):247–272.
  • Sjukhusförvärvad pneumoni – behandlingsrekommendation. Information från Läkemedelsverket. Swedish Medical Products Agency. 2016;1(1):17–30. https://lakemedelsverket.se/pneumoni.
  • FDA. Statistical guidance on reporting results from studies evaluating diagnostic tests. 2007 [cited 2020 Mar 30]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-guidance-reporting-results-studies-evaluating-diagnostic-tests-guidance-industry-and-fda
  • Garcia-Vidal C, Carratalà J. Early and late treatment failure in community-acquired pneumonia. Semin Respir Crit Care Med. 2009;30(02):154–160.
  • The Dutch Working Party on Antibiotic Policy (SWAB)/Dutch Association of Chest Physicians (NVALT). Dutch Guidelines on the Management of Community-Acquired Pneumonia in Adults. 2011. (November):1–95.
  • Mandell L. a, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Supplement_2):S27–S72.
  • Messacar K, Parker SK, Todd JK, et al. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol. 2017;55(3):715–723.
  • Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415–427.
  • Rabenau HF, Kessler HH, Kortenbusch M, et al. Verification and validation of diagnostic laboratory tests in clinical virology. J Clin Virol. 2007;40(2):93–98.